Home News Company in the news

SATS able to transport Pfizer’s experimental Covid-19 vaccine at low temperatures: CEO

Jeffrey Tan
Jeffrey Tan11/12/2020 08:04 PM GMT+08  • 1 min read
SATS able to transport Pfizer’s experimental Covid-19 vaccine at low temperatures: CEO
“We are certified to handle at that temperature,” says SATS CEO Alex Hungate.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Airline caterer SATS, which also handles airfreight and other gateway services, has the capabilities to transport the experimental Covid-19 vaccine developed by Pfizer, according to CEO Alex Hungate.

Pfizer’s Covid-19 vaccine, according to news reports, is required to be kept at -70 degrees Celsius.

Such a requirement could be an obstacle in ensuring the integrity of the vaccine during transportation.

Nevertheless, Hungate assures that the company, its subsidiaries and associates are CEIV Pharma certified.

This certification indicates that SATS’s facilities, equipment, operations and staff comply with all applicable standards, regulations and guidelines expected from pharmaceutical manufacturers.

Hungate says SATS can use liquid nitrogen to keep the vaccine at -70 degrees Celsius.

In fact, the company has handled shipments under similar temperatures before, he adds.

“We are certified to handle at that temperature,” he says at SATS’s 1HFY2021 results briefing this evening.

SATS closed up 7 cents or 2% at $3.60 on Nov 12, with 5.2 million shares changed hands.

×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.